New therapeutic targets in idiopathic pulmonary fibrosis. Aiming to rein in runaway wound-healing responses.
about
Recent advances in understanding idiopathic pulmonary fibrosisMyriad Functions of Stanniocalcin-1 (STC1) Cover Multiple Therapeutic Targets in the Complicated Pathogenesis of Idiopathic Pulmonary Fibrosis (IPF)Pharmacological Treatment of Idiopathic Pulmonary Fibrosis: Current Approaches, Unsolved Issues, and Future PerspectivesPharmacological treatment of idiopathic pulmonary fibrosis - preclinical and clinical studies of pirfenidone, nintedanib, and N-acetylcysteineThe Rho kinases: critical mediators of multiple profibrotic processes and rational targets for new therapies for pulmonary fibrosisMAP3K19 Is a Novel Regulator of TGF-β Signaling That Impacts Bleomycin-Induced Lung Injury and Pulmonary FibrosisThe extracellular matrix - the under-recognized element in lung disease?A MALDI-MSI Approach to the Characterization of Radiation-Induced Lung Injury and Medical Countermeasure DevelopmentWhat We Talk About When We Talk About EvolutionUncoupling of the profibrotic and hemostatic effects of thrombin in lung fibrosis.Nintedanib in the treatment of idiopathic pulmonary fibrosis.Validation of the 2nd Generation Proteasome Inhibitor Oprozomib for Local Therapy of Pulmonary Fibrosis.Safety, tolerability and appropriate use of nintedanib in idiopathic pulmonary fibrosis.FK506-Binding Protein 10, a Potential Novel Drug Target for Idiopathic Pulmonary FibrosisNovel Mechanisms for the Antifibrotic Action of Nintedanib.Keloids: Animal models and pathologic equivalents to study tissue fibrosis.Autotaxin activity increases locally following lung injury, but is not required for pulmonary lysophosphatidic acid production or fibrosisTargeted Therapy for Idiopathic Pulmonary Fibrosis: Where To Now?Fibrogenic Lung Injury Induces Non-Cell-Autonomous Fibroblast InvasionSerum extracellular vesicular miR-21-5p is a predictor of the prognosis in idiopathic pulmonary fibrosis.A Systematic Review of the Role of Dysfunctional Wound Healing in the Pathogenesis and Treatment of Idiopathic Pulmonary Fibrosis.Inflammatory response mechanisms exacerbating hypoxemia in coexistent pulmonary fibrosis and sleep apnea.Nintedanib: A Review of Its Use in Patients with Idiopathic Pulmonary Fibrosis.Cell-based therapies for the treatment of idiopathic pulmonary fibrosis (IPF) disease.Nintedanib reduces ventilation-augmented bleomycin-induced epithelial-mesenchymal transition and lung fibrosis through suppression of the Src pathway.Greater endurance capacity and improved dyspnoea with acute oxygen supplementation in idiopathic pulmonary fibrosis patients without resting hypoxaemia.Newer developments in idiopathic pulmonary fibrosis in the era of anti-fibrotic medications.Annexin A2 contributes to lung injury and fibrosis by augmenting factor Xa fibrogenic activity.Tissue remodelling in pulmonary fibrosis.Diagnosis and Treatment of Fibrotic Hypersensitivity Pneumonia. Where We Stand and Where We Need to Go.Lrp5/β-Catenin Signaling Controls Lung Macrophage Differentiation and Inhibits Resolution of Fibrosis.Germline SFTPA1 mutation in familial idiopathic interstitial pneumonia and lung cancer.ICOS protects against mortality from acute lung injury through activation of IL-5+ ILC2s.Exploring Animal Models That Resemble Idiopathic Pulmonary Fibrosis.HYDAMTIQ, a selective PARP-1 inhibitor, improves bleomycin-induced lung fibrosis by dampening the TGF-β/SMAD signalling pathway.Molecular imaging of oxidized collagen quantifies pulmonary and hepatic fibrogenesisPermanent alveolar collapse is the predominant mechanism in idiopathic pulmonary fibrosis.Stem-cell extracellular vesicles and lung repair.Autophagy and the Unfolded Protein Response Promote Pro-fibrotic Effects of TGFβ1 in Human Lung Fibroblasts.Therapeutic effects of telomerase in mice with pulmonary fibrosis induced by damage to the lungs and short telomeres.
P2860
Q26745905-D4E6B728-3F06-4821-AB65-A60374E1E4C4Q26770376-FEE44147-3D06-47A8-8C67-1839B17E09D5Q26771309-345ED797-584C-4F2C-BC7B-01859366DA49Q26777928-B1370B63-2630-4B5F-BD82-4CC4DE181E72Q27005980-85DA1A14-3250-4311-82EA-95AB16D75892Q27348347-B540ADD3-35D0-4DEA-AF3C-663C564A6FD3Q28075842-6CE90B67-0620-4A3F-B48A-703858A6FF99Q28386213-01130F84-796C-430E-AC41-7C23E7BB5811Q28603812-3E869D3C-4705-42B2-B5BA-2B6B8A502164Q33631115-D1BD72DD-833C-402D-97FD-89E0418E702EQ34471193-D462C03D-DAD1-4252-8062-D60C592FB530Q35764713-D4BA45D9-0F61-408A-92A7-9EFE61C9C5A6Q36089113-5B511A45-C923-4C21-ADB3-EDCD0CFEC6E2Q36128503-AEAA44CC-D2A3-4B83-B7B4-610807477C34Q36549047-D22D4031-4137-4655-B770-50DB9CDA2C8AQ36828407-907A370C-8932-4F29-8283-A6B04709050AQ36913763-B81829F1-51EF-4063-99F9-8E655F5C8F61Q37080510-51B6A9B1-5D6F-4616-AB57-F8C4B9CF6C88Q37088303-1C4F2864-952C-4874-BE00-D2BDF86FC7BBQ37233229-EFD65815-37B0-4BAD-9483-4726E621180AQ37628170-0902CDC0-8B37-40C2-9A27-D1E3F9D8C3CAQ38461691-13614D6B-1ED4-4A66-8BAB-9BF6360D9D9CQ38524352-1FCC06B5-ED94-4D4C-9230-D0B0538FD024Q38642870-3A93C6D0-B538-4E68-8EE6-553418312565Q38734546-568DD14B-84CE-47F4-A7F1-C29053F3CFE8Q38754565-2091C01F-2928-4A00-8123-BBEDD0F41DADQ38812037-7AA38BBD-7376-4357-AEC3-F97FB909E208Q38914096-DDA46E21-3B32-4D80-A20E-53E09CEB1927Q39040828-9C28E43D-46B3-431A-8BD8-F20A03365C14Q39047042-CB99F07F-1C19-43BD-AD18-DFFC68B0651CQ39351661-A426A5E1-73B5-4652-8344-D559B5EDBD25Q40081417-4FD5E1EA-DBE7-4DCE-B152-490B6F55D7E2Q40219134-7CB9FC91-4E4B-49F2-A146-38C1B5C87167Q41159764-52AE398C-C9AD-4D14-B84B-674AE6457968Q42021947-4FF84D41-6C0E-4BAE-82C9-CC6BFD1021E1Q42230916-554D778E-3E60-471B-8000-F19A4CECA345Q42479603-92973186-3220-4C43-AD80-653A7555BE7FQ45542402-F2A10E94-62A0-4DB0-804B-013351D28E00Q45970202-D4F9E6EC-4435-4E2B-B436-0FA874B515F3Q47524535-1F9429B1-5DC7-43F4-B763-17BEAEC340BE
P2860
New therapeutic targets in idiopathic pulmonary fibrosis. Aiming to rein in runaway wound-healing responses.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
New therapeutic targets in idi ...... naway wound-healing responses.
@ast
New therapeutic targets in idi ...... naway wound-healing responses.
@en
New therapeutic targets in idi ...... naway wound-healing responses.
@nl
type
label
New therapeutic targets in idi ...... naway wound-healing responses.
@ast
New therapeutic targets in idi ...... naway wound-healing responses.
@en
New therapeutic targets in idi ...... naway wound-healing responses.
@nl
prefLabel
New therapeutic targets in idi ...... naway wound-healing responses.
@ast
New therapeutic targets in idi ...... naway wound-healing responses.
@en
New therapeutic targets in idi ...... naway wound-healing responses.
@nl
P2093
P2860
P1476
New therapeutic targets in idi ...... naway wound-healing responses.
@en
P2093
Andrew M Tager
Barry S Shea
Neil Ahluwalia
P2860
P304
P356
10.1164/RCCM.201403-0509PP
P407
P577
2014-10-01T00:00:00Z